APA (7th ed.) Citation

Rasmussen, N. B., Deligianni, C., Christensen, C. E., Karlsson, W. K., Al-Khazali, H. M., Van de Casteele, T., . . . Ashina, M. (2023). The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: An interventional, randomized, double-blind, parallel-group, placebo-controlled study. Journal of headache and pain, 24(1), 60-12. https://doi.org/10.1186/s10194-023-01599-w

Chicago Style (17th ed.) Citation

Rasmussen, Nadja Bredo, Christina Deligianni, Casper Emil Christensen, William Kristian Karlsson, Haidar Muhsen Al-Khazali, Tom Van de Casteele, Charlotte Granhall, Faisal Mohammad Amin, and Messoud Ashina. "The Effect of Lu AG09222 on PACAP38- and VIP-induced Vasodilation, Heart Rate Increase, and Headache in Healthy Subjects: An Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study." Journal of Headache and Pain 24, no. 1 (2023): 60-12. https://doi.org/10.1186/s10194-023-01599-w.

MLA (9th ed.) Citation

Rasmussen, Nadja Bredo, et al. "The Effect of Lu AG09222 on PACAP38- and VIP-induced Vasodilation, Heart Rate Increase, and Headache in Healthy Subjects: An Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study." Journal of Headache and Pain, vol. 24, no. 1, 2023, pp. 60-12, https://doi.org/10.1186/s10194-023-01599-w.